Oleuropein / PPARγ Cancer Research Results

OLE, Oleuropein: Click to Expand ⟱
Features:
Oleocanthal is essentially found ONLY in: Fresh, unrefined extra-virgin olive oil (EVOO)
It is part of the pungent, throat-stinging phenolic fraction that disappears in refined oils.

Oleuropein (OLEU) — a secoiridoid polyphenol from olive leaf and olive fruit/extra-virgin olive oil; major in-vivo related phenolic is hydroxytyrosol (via hydrolysis/metabolism). Sources: olive leaf extract (standardized to oleuropein), EVOO phenolics.

Primary mechanisms (conceptual rank):
1) Redox modulation (ROS ↓ in normal tissue; stress/hormesis; NRF2 ↑ context-dependent)
2) Anti-inflammatory transcription suppression (NF-κB ↓)
3) Anti-proliferative signaling in cancer models (PI3K/AKT/mTOR ↓; MAPK modulation; apoptosis ↑; model-dependent)
4) Anti-angiogenic / hypoxia coupling (HIF-1α/VEGF ↓; model-dependent)

Bioavailability / PK relevance: Human data show absorption/metabolism after oral olive leaf extract; circulating forms are largely metabolites (and hydroxytyrosol-related), with limited free parent compound exposure. :contentReference[oaicite:0]{index=0}

In-vitro vs oral exposure: Many direct “anticancer” cytotoxic effects occur at micromolar concentrations that may exceed typical systemic exposure from supplements/foods (high concentration only for direct tumor cytotoxicity in many models). :contentReference[oaicite:1]{index=1}

Clinical evidence status: Nutraceutical/food bioactive with human data mainly for cardiometabolic/inflammation endpoints; oncology evidence largely preclinical/adjunct-hypothesis (no oncology approval).

Also available as a supplement usually labeled as Olive Leaf Extract. (20-50% concentrations)
- commonly used in CSC (Cancer Stem Cell) research.
Main CSC mechanisms:
-Inhibits Wnt/β-catenin — a core CSC survival pathway
-↓ALDH (Reduces ALDH-high CSC subpopulations)
-downregulates stemness geens: SOX2/OCT4/Nanog → reduced sphere formation/self-renewal.

Oleuropein — Cancer vs Normal Cell Pathway Map

RankPathway / AxisCancer CellsNormal CellsTSFPrimary EffectNotes / Interpretation
1ROS ↑ or ↓ (dose-/model-dependent)↓ (primary)P/R Redox reprogramming Normal tissue: antioxidant/lipid-peroxidation reduction common. Cancer: higher exposures can induce stress/apoptosis; direction varies by model and co-stressors.
2NF-κB / cytokine programs ↓↓R/G Anti-inflammatory / anti-survival transcription Commonly reported mechanism for oleuropein/olive phenolics. :contentReference[oaicite:3]{index=3}
3NRF2 (protective vs resistance role) ↔ / ↑ (context-dependent)↑R/G Antioxidant gene induction NRF2 modulation is frequently discussed for olive polyphenols; in cancer contexts can be double-edged (cytoprotection/resistance). :contentReference[oaicite:4]{index=4}
4PI3K/AKT/mTOR ↓ (model-dependent; high concentration only)↔R/G Reduced anabolic survival signaling Reported across cancer models and olive phenolic literature; translation depends on exposure. :contentReference[oaicite:5]{index=5}
5Intrinsic apoptosis (Bax↑/Bcl-2↓; caspases) ↑ (model-dependent; high concentration only)↔R/G Mitochondrial apoptosis Common downstream endpoint in preclinical cancer work; often coupled to redox and PI3K/AKT shifts. :contentReference[oaicite:6]{index=6}
6HIF-1α / VEGF (angiogenesis) ↓ (model-dependent)↔G Reduced hypoxia-adaptation / vascular support Typically secondary; varies strongly by model and readout.
7Cell cycle checkpoints ↓ proliferation (model-dependent)↔G Cytostatic growth restraint Often reported as G0/G1 or G2/M arrest in vitro; exposure gap is common. :contentReference[oaicite:7]{index=7}
8Ferroptosis ↔ (limited / context-dependent)↔R/G Not canonical Olive phenolics can influence lipid peroxidation, but a consistent oleuropein-driven ferroptosis program is not a core claim in the main reviews.
9Ca²⁺ signaling ↔↔P/R No primary role Include only if a specific ER/mitochondrial stress model measures Ca²⁺ endpoints.
10Clinical Translation Constraint ↓ (constraint)↓ (constraint)— Metabolite-dominant exposure Human absorption/metabolism exists, but many tumor-directed effects rely on higher in-vitro exposures; extract standardization and formulation matter. :contentReference[oaicite:8]{index=8}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr



Oleuropein — AD relevance: Oleuropein/olive leaf phenolics show neuroprotection in models via oxidative- and heat-shock/proteostasis stress responses, with reported reduction of Aβ and tau proteotoxicity in preclinical systems; human AD disease-modifying evidence is not established.

Primary mechanisms (conceptual rank):
1) ↓ Oxidative stress (ROS ↓; lipid peroxidation ↓; NRF2-linked defense ↑)
2) ↓ Neuroinflammation (NF-κB tone ↓)
3) Proteostasis support (heat-shock/stress-response pathways; context-dependent)
4) Aβ/tau proteotoxicity ↓ (preclinical)

Bioavailability / PK relevance: Human absorption/metabolism supports systemic exposure mainly as metabolites; brain relevance likely chronic/adaptive. :contentReference[oaicite:9]{index=9}

Clinical evidence status: Predominantly preclinical for AD mechanisms; limited AD-specific clinical endpoint evidence.

Oleuropein — AD / Neurodegeneration Pathway Map

RankPathway / AxisCellsTSFPrimary EffectNotes / Interpretation
1ROS / lipid peroxidation ↓P/R Reduced oxidative burden Central neuroprotection rationale for olive polyphenols (includes oleuropein/hydroxytyrosol pathways). :contentReference[oaicite:11]{index=11}
2NRF2 axis ↑ (context-dependent)R/G Stress-defense upshift NRF2 modulation is repeatedly discussed for olive polyphenols in cognition-related health framing. :contentReference[oaicite:12]{index=12}
3Neuroinflammation (NF-κB / cytokines) ↓R/G Lower inflammatory stress Often paired with antioxidant effects; model-dependent magnitude.
4Proteostasis / heat-shock stress responses ↑ (supportive)R/G Improved handling of misfolded proteins Oleuropein-rich olive leaf extract reduced Aβ and tau proteotoxicity via oxidative/heat-shock stress regulation in a C. elegans model. :contentReference[oaicite:13]{index=13}
5Aβ / tau proteotoxicity ↓ (preclinical)G Reduced pathology-linked toxicity Evidence is stronger in models than in biomarker-confirmed human AD studies. :contentReference[oaicite:14]{index=14}
6Ca²⁺ homeostasis / excitotoxic vulnerability ↔ / stabilized (indirect)P/R Supportive (secondary) Typically secondary to mitochondrial/redox support unless a study explicitly measures Ca²⁺ endpoints.
7Clinical Translation Constraint ↓ (constraint)— Preclinical-dominant AD evidence Most AD-relevant mechanisms are model-based; human AD efficacy endpoints remain limited. :contentReference[oaicite:15]{index=15}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr
PPARγ, Peroxisome proliferator-activated receptor gamma (PPAR-γ or PPARG): Click to Expand ⟱
Source:
Type:
Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a type of nuclear receptor that plays a crucial role in regulating various biological processes, including glucose metabolism, lipid metabolism, and inflammation. It is primarily expressed in adipose tissue, but it is also found in other tissues, including the colon, breast, and prostate.
PPAR-γ has been shown to have both tumor-suppressive and tumor-promoting effects, depending on the type of cancer and the context. In some cancers, activation of PPAR-γ can inhibit cell proliferation and induce apoptosis, while in others, it may promote tumor growth.
PPARγ
– Plays a central role in adipogenesis, lipid storage, and insulin sensitivity.
– Widely expressed in adipose tissue, but also present in colon, breast, and immune cells.
– In addition to metabolic functions, PPARγ regulates cell differentiation, apoptosis, and has anti-inflammatory effects.
– Ligand binding (such as endogenous fatty acids or synthetic agonists like thiazolidinediones) alters transcriptional programs impacting cell cycle and survival.

– In many cases, PPARγ is expressed in tumor cells, and its activation has been linked to induction of differentiation and growth arrest.
– However, expression levels can differ based on tumor subtype, with some studies reporting elevated levels while others note reductions in aggressive tumors.
– Crosstalk with other signaling pathways (e.g., Wnt/β-catenin, MAPK) can alter PPARγ's net effect in cancer cells.
Scientific Papers found: Click to Expand⟱
4643- OLE,  HT,    Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
- Review, Var, NA
TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Catalase↓, 1,   NOX4↑, 1,   ROS↑, 1,   SIRT3↓, 1,   SOD2↓, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Core Metabolism/Glycolysis ⓘ

FASN↓, 1,   PPARγ↑, 1,  

Cell Death ⓘ

Akt↓, 1,   Apoptosis↑, 1,   BAD↑, 1,   Bak↑, 1,   BAX↑, 1,   Bcl-2↓, 1,   Casp3↑, 1,   Casp9↑, 1,   p27↑, 1,  

Protein Folding & ER Stress ⓘ

CHOP↑, 1,   ER Stress↑, 1,   UPR↑, 1,  

DNA Damage & Repair ⓘ

P53↑, 1,   PARP↑, 1,  

Cell Cycle & Senescence ⓘ

P21↑, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

HDAC2↓, 1,   HDAC3↓, 1,   mTOR↓, 1,   STAT3↓, 1,  

Migration ⓘ

MMP2↓, 1,  

Angiogenesis & Vasculature ⓘ

Hif1a↓, 1,   VEGF↓, 1,  

Immune & Inflammatory Signaling ⓘ

NF-kB↓, 1,   p65↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↓, 2,   Half-Life↝, 1,   RadioS↑, 1,   selectivity↑, 1,  
Total Targets: 37

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

Catalase↑, 1,   GSH↑, 1,   MDA↓, 1,   NRF2↑, 1,   ROS↓, 1,   SOD↑, 1,  

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,  

Functional Outcomes ⓘ

chemoP↑, 1,  
Total Targets: 8

Scientific Paper Hit Count for: PPARγ, Peroxisome proliferator-activated receptor gamma (PPAR-γ or PPARG)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:375  Target#:259  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page